Nurix Therapeutics Chief Legal Officer Christine Ring reports common share disposal worth $134,160.79
NRIX•Christine Ring sold 5,786 Nurix Therapeutics shares for $134,160.79 after exercising 5,786 stock options, leaving her with 9,110 directly held shares and 111,251 options.
1. Share sale and holdings
Nurix Therapeutics Chief Legal Officer Christine Ring sold 5,786 common shares on Oct. 2, 2026, at $23.1851 per share, after exercising 5,786 employee stock options at $8.72 each. Her directly held common shares fell to 9,110, while her directly held employee stock options increased to 111,251.
